Reports Q4 revenue $246.6M, consensus $245.82M. “Our outstanding results in 2023 underscore the power of the Hims & Hers brands and superior execution across the organization,” said Andrew Dudum, co-founder and CEO. “We are continuing to advance our mission to make the world feel great through the power of better health, which is evident in the significant, consistent and category-leading revenue growth and market share gains we have been delivering. In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability through a continued focus on building personalized and accessible treatments in each of our core specialties. We believe this approach will meaningfully break down barriers that keep individuals from seeking treatment, which will allow us to bring these unique offerings to tens of millions of subscribers over time.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HIMS:
- HIMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Hims & Hers price target raised to $15 from $14 at Tigress Financial
- DA Davidson keeps Buy on WW after selloff on Lilly news
- The beauty and wellness stocks to own in 2024, according to Piper Sandler
- Hims & Hers price target raised to $9 from $7 at Piper Sandler